Charles Shuff, MD
Orthopaedic Surgery · Norfolk, VANPI 1437248622
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Spineology Inc. accounts for 89.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $8,122 and has fallen 85.7% since, to $1,161 in 2025.
Across 38 payments — averaging $455.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spineology Inc.$16K
- Fortis Surgical, LLC$627
- Arthrex$494
- Globus Medical$282
- Choice Spine, LLC$102
- Medtronic$101
- plus $163 from 6 others
What the payments were for
- Consulting fees$4,00023%
- Speaking & faculty fees$5,25030%
- Travel & lodging$6,80839%
- Food & beverage$1,2377%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spineology Inc. | 15 | $15,526 |
| Fortis Surgical, LLC | 2 | $627 |
| Arthrex | 5 | $494 |
| Globus Medical | 3 | $282 |
| Choice Spine, LLC | 1 | $102 |
| Medtronic | 6 | $101 |
| Bioventus LLC | 1 | $47 |
| Centinel Spine, LLC | 1 | $29 |
| Johnson & Johnson | 1 | $27 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| VB Spine LLC | 1 | $20 |
| Endo USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$8,028
- OptiMesh Interbody Fusion System$6,820
- OptiMesh Graft Containment$500
- Excelsius - GPS$261
- Blackhawk$102
- Tiger Shark$102
- Blackbird$102
- Tomcat$102
- VEO$102
How this compares
$17,294 in reported general payments places this provider in the 75th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 378 | $7,723 |
| Gabapentin | 143 | $1,327 |
| Tizanidine Hcl | 116 | $1,228 |
| Cyclobenzaprine Hcl | 45 | $506 |
| Methocarbamol | 69 | $476 |
| Duloxetine Hcl | 30 | $423 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $398 |
| Diclofenac Sodium | 14 | $319 |
| Methylprednisolone | 27 | $197 |
| Prednisone | 55 | $196 |
| Baclofen | 25 | $196 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $165 |
| Meloxicam | 53 | $137 |
| Ondansetron Hcl | 12 | $114 |
| Oxycodone Hcl | 18 | $111 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Norfolk
- Michael CampbellNorfolk$517K
- John ByrdNorfolk$80K
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.1M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- Randall PeytonSterling$2.9M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.